| NDA | National Dental Association; New Drug Application; no data available; no detectable activity; no detectable antibody |
|---|---|
| NDAC | not data accepted |
| NDATUS | National Drug and Alcoholism Treatment Unit Survey |
| NDA | Naphthalene-2,3-dicarboxaldehyde |
|---|---|
| NDA | New Drug Application |
| nda | New Drug Application An application to the FDA for approval to market a drug in the U.S. The FDA determines if a protein pharmaceutical is considered a drug or a biologic and whether an NDA or a PLA, respectively, should be filed to obtain marketing approval. (14 Nov 1997) |
|---|
| NDA |
An application submitted by the manufacturer of a drug to the FDA-after clinical trials have been completed-for a license to market the drug for a specified indication.
출처: www.amfar.org/cgi-bin/iowa/bridge.html
|
|---|---|
| NDA |
an application made by a drug sponsor to FDA to request marketing approval.
출처: www.sfaf.org/treatment/beta/b29/b29glos.html
|
| NDA |
an application to the FDA asking for approval to market a new drug.
출처: www.gmhc.org/health/glossary3.html
|
| NDA |
Application filed with the Food and Drug Administration to obtain approval to market a prescription drug.
출처: www.sdrpharma.com/sj.htm
|
| NDA |
Application filed by a manufacturer to market a drug in the US, contains all known nonclinical, clinical, pharmacological, pharmacokinetic, and stability data about the drug
출처: www.dcri.duke.edu/patient/glossary.jsp
|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|